Repaglinide 2 mg Australia

Description

Introduction

Repaglinide 2 mg Australia is presented as a tablet containing 2 mg of the active ingredient repaglinide. Repaglinide is a glucose-lowering medicine used in the management of type 2 diabetes. Its use requires attention to meals, blood glucose levels and other medicines. Australian registration status and the inactive ingredients of this particular product have not been verified. Ask a pharmacist or other healthcare professional for product-specific guidance.

What Is It?

Repaglinide belongs to a group of medicines called glinides, also known as meglitinides. It is taken by mouth and acts around mealtimes. The stated 2 mg strength describes the amount of repaglinide in each tablet; it does not establish the dose appropriate for any individual. A healthcare professional considers the wider diabetes treatment plan, medical history and other medicines when assessing its use.

How Does It Work?

Repaglinide stimulates the pancreas to release insulin. Insulin helps the body’s cells take up glucose from the blood. This action can reduce blood glucose levels, including rises associated with meals. Because the medicine increases insulin release, blood glucose may also fall too low. This risk is particularly relevant when meals are missed or other glucose-lowering medicines are used.

Common Uses

Repaglinide is used alongside diet and exercise to improve blood glucose control in adults with type 2 diabetes. It may be prescribed alone or within a broader diabetes treatment plan. Repaglinide is not used to treat type 1 diabetes or diabetic ketoacidosis. A clinician can assess whether repaglinide, and this tablet strength, fits an individual treatment plan.

Available Strengths

• Repaglinide 0.5 mg Australia
• Repaglinide 1 mg Australia
• Repaglinide 2 mg Australia

Key Features

• The stated active ingredient is repaglinide.
• The product is presented as an oral tablet containing 2 mg of repaglinide.
• Repaglinide is a glinide medicine that stimulates insulin release.
• Its use is linked to meals because food intake affects the risk of low blood glucose.
• The inactive ingredients of this particular tablet have not been verified. Anyone needing that information should check the supplied pack with a pharmacist.

Benefits

• Repaglinide can improve blood glucose control in adults with type 2 diabetes when used as part of an appropriate treatment plan.
• Its action around meals can help address meal-related rises in blood glucose.
• Blood glucose measurements and HbA1c tests give healthcare professionals ways to assess the response to treatment.

Possible Side Effects

• Low blood glucose, or hypoglycaemia, is an important risk. Warning signs can include sweating, shakiness, hunger, dizziness, headache or weakness.
• More severe hypoglycaemia can cause confusion, seizures or loss of consciousness. These symptoms require urgent medical attention.
• Other reported side effects include headache, constipation, diarrhoea, back pain, joint aches and nasal congestion.
• Side effects vary between people. A healthcare professional can assess symptoms that are severe, persistent or concerning.

Precautions

• Tell a healthcare professional about any previous allergic reaction to repaglinide or concerns about tablet ingredients.
• Discuss liver or kidney disease, as these conditions may affect treatment decisions and monitoring.
• Ask a healthcare professional how to recognise and manage low blood glucose within an individual diabetes care plan.
• Discuss pregnancy, plans for pregnancy or breastfeeding before using repaglinide.
• Repaglinide is not a treatment for type 1 diabetes or diabetic ketoacidosis. These conditions require separate clinical care.

Additional Precautions

• Changes in meals, physical activity or alcohol intake may affect blood glucose and the risk of hypoglycaemia.
• Illness or difficulty eating may change diabetes management needs. Seek guidance about the existing care plan if these circumstances arise.
• Tell doctors and dentists about repaglinide before surgery or dental procedures.
• Keep scheduled blood glucose and HbA1c checks so treatment response can be reviewed.
• Check the supplied pack and directions with a pharmacist if there is uncertainty about product identity, ingredients or use.

Storage Instructions

• Keep the tablets in their original packaging and out of the sight and reach of children.
• Store at room temperature, away from excess heat and moisture.
• Avoid storing medicines in a bathroom, where humidity can be high.
• Follow any more specific storage directions supplied with the actual pack.
• Ask a pharmacist about disposal of expired or unwanted tablets.

How to Take

• Repaglinide is an oral tablet used in relation to meals. Follow the directions provided by the prescribing healthcare professional and with the supplied medicine.
• The prescribed dose and timing depend on the treatment plan and blood glucose response. A 2 mg tablet strength does not determine an individual dose.
• Missing a meal affects how repaglinide is used because taking it without food can increase the risk of hypoglycaemia. Follow the individual plan provided by a healthcare professional.
• Do not take a double dose to make up for a missed dose. Ask a pharmacist or prescriber if the directions are unclear.

Drug Interactions

• Gemfibrozil markedly increases exposure to repaglinide and must not be used with it.
• Clopidogrel can substantially increase repaglinide exposure. The combination should generally be avoided unless a clinician determines how to manage it.
• Certain antibiotics and antifungal medicines, including erythromycin, clarithromycin, ketoconazole and itraconazole, may affect repaglinide levels.
• Other glucose-lowering medicines may increase the risk of hypoglycaemia when used with repaglinide.
• Some medicines, including certain beta blockers, may make warning signs of low blood glucose harder to recognise.
• Provide a healthcare professional with a current list of prescription medicines, non-prescription products and supplements when treatment is reviewed.

Why Choose This Product?

• It provides the stated active ingredient, repaglinide, in a 2 mg oral tablet form when that strength has been prescribed.
• Repaglinide has an established role in improving blood glucose control in adults with type 2 diabetes.
• Its meal-related action is a characteristic a clinician may consider alongside meal patterns and other treatment needs.
• Suitability of this particular product depends on a clinical review and confirmation of the supplied pack details.

Frequently Asked Questions (FAQs)

What is the active ingredient?

The stated active ingredient is repaglinide, at a strength of 2 mg per tablet.

What type of medicine is repaglinide?

It is a glinide medicine that stimulates insulin release from the pancreas.

What is repaglinide used for?

It is used alongside diet and exercise to improve blood glucose control in adults with type 2 diabetes.

Can repaglinide cause low blood glucose?

Yes. Hypoglycaemia is an important risk, especially when food intake changes or other glucose-lowering medicines are used.

Is repaglinide used for type 1 diabetes?

No. Repaglinide is not a treatment for type 1 diabetes or diabetic ketoacidosis.

What if a meal is missed?

A missed meal affects how repaglinide is used. Follow the plan provided by the prescriber or ask a pharmacist for guidance.

Can it interact with other medicines?

Yes. Gemfibrozil must not be combined with repaglinide, and clopidogrel also requires particular attention. A healthcare professional can check the full medicine list.

What monitoring is involved?

Blood glucose measurements and HbA1c tests are commonly used to assess diabetes control and treatment response.

Are the inactive ingredients known?

The inactive ingredients of this particular product have not been verified. Check the supplied pack with a pharmacist if this information matters, especially for an allergy concern.